Trial intelligence / Profile preview

Analgesic efficacy of nefopam in cancer pain

TCTR20181016001Phase 3Completed

Sponsor
Ramathibodi Hospital
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nefopam in cancer pain, sponsored by Ramathibodi Hospital. Started Oct 2018; status: completed.

02

Drugs

nefopam
03

Conditions

cancer pain

Beyond the preview

Go deeper on TCTR20181016001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20181016001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call